Both in Pharmaceuticals
Mustang Bio vs Onconetix
Over the past year MBIO returned −69.5% and ONCO returned −99.5%; their daily moves had a correlation of 0.06.
MBIO −69.5% ONCO −99.5%Growth of $1, one year, split-adjusted
| Metric | MBIO | ONCO |
|---|---|---|
| Price | $0.4796 | $0.8200 |
| Market cap | $3.6M | $3.6M |
| Today | −5.39% | −26.13% |
| 1 month | −10.8% | +33.9% |
| 6 months | −33.9% | −94.8% |
| Year to date | −51.1% | −98.9% |
| 1 year | −69.8% | −99.5% |
| Revenue growth (YoY) | — | −83.9% |
| Gross margin | — | 25.1% |
| Net margin | — | −16748.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 5.6× |
| Net cash | $15.2M | $5.8M |
| Dividend yield | — | — |
| Volatility (60d) | 58.0% | 161.1% |
| Short % of float | 0.9% | 4.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).